Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Borderline serous cystadenocarcinoma with coexistent angiosarcoma: an unusual form of ovarian carcinosarcoma.

Pillay K, Essa AS, Chetty R.

Int J Surg Pathol. 2001 Oct;9(4):317-21.

PMID:
12574850
2.

Carcinosarcoma of ovary with its various immunohistochemical expression: Report of a rare case.

Dasgupta S, Bose D, Bhattacharyya NK, Biswas PK.

J Cancer Res Ther. 2015 Oct-Dec;11(4):1022. doi: 10.4103/0973-1482.147390.

3.

Ovarian carcinosarcoma associated with bilateral tubal intraepithelial carcinoma: a case report.

Brustmann H.

Int J Gynecol Pathol. 2013 Jul;32(4):384-9. doi: 10.1097/PGP.0b013e318264aece.

PMID:
23722511
4.

Serous ovarian carcinoma recurring as a heterologous carcinosarcoma.

Ferrandina G, Carbone A, Zannoni GF, Martinelli E, Testa AC, Gallotta V, De Ninno M, Scambia G.

J Obstet Gynaecol Res. 2007 Feb;33(1):95-9.

PMID:
17212675
5.

Serous papillary adenocarcinoma and adult granulosa cell tumor in the same ovary. An unusual case.

Ozbey C, Erdogan G, Pestereli HE, Simsek T, Karaveli S.

APMIS. 2005 Oct;113(10):713-5.

PMID:
16309432
6.

Serous papillary cystadenocarcinoma arising from autografted ovary of the abdominal wall.

Gong W, Cheng H, Yan Q, Huang G, Luo P, Wang Z.

Int J Surg Pathol. 2010 Oct;18(5):398-400. doi: 10.1177/1066896908325875. Epub 2009 Jan 14.

PMID:
19147508
7.

Characterization of a human carcinosarcoma cell line of the ovary established after in vivo change of histologic differentiation.

Möbus VJ, Gerharz CD, Weikel W, Merk O, Dreher L, Kreienberg R, Moll R.

Gynecol Oncol. 2001 Dec;83(3):523-32.

PMID:
11733966
8.

Endometrioid adenocarcinoma of the ovary mimicking serous borderline tumor: report of a series of cases.

Mansor S, McCluggage WG.

Int J Gynecol Pathol. 2014 Sep;33(5):470-6. doi: 10.1097/PGP.0000000000000087.

PMID:
25083962
9.

Loss of SerpinA5 protein expression is associated with advanced-stage serous ovarian tumors.

Bijsmans IT, Smits KM, de Graeff P, Wisman GB, van der Zee AG, Slangen BF, de Bruïne AP, van Engeland M, Sieben NL, Van de Vijver KK.

Mod Pathol. 2011 Mar;24(3):463-70. doi: 10.1038/modpathol.2010.214. Epub 2010 Nov 19.

10.

[Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].

Shao HL, Shen DH, Xue WC, Li Y, Yu YZ.

Zhonghua Fu Chan Ke Za Zhi. 2007 Apr;42(4):227-32. Chinese.

PMID:
17631760
11.

Ovarian low-grade serous carcinoma involving the cervix mimicking a cervical primary.

Malpica A, Deavers MT.

Int J Gynecol Pathol. 2011 Nov;30(6):613-9. doi: 10.1097/PGP.0b013e318217137e.

PMID:
21979600
12.

Carcinosarcoma of the ovary compared to papillary serous ovarian carcinoma: a SEER analysis.

Rauh-Hain JA, Diver EJ, Clemmer JT, Bradford LS, Clark RM, Growdon WB, Goodman AK, Boruta DM 2nd, Schorge JO, del Carmen MG.

Gynecol Oncol. 2013 Oct;131(1):46-51. doi: 10.1016/j.ygyno.2013.07.097. Epub 2013 Jul 29.

PMID:
23906658
13.

Borderline mucinous cystic ovarian tumor with mural nodules (carcinosarcoma).

Chang JS, Chua CC, Lee CC.

Ann Saudi Med. 2012 Jul-Aug;32(4):415-20. Review.

14.

Malignant melanoma arising in an ovarian carcinosarcoma: case report and review of the literature.

Roma AA, Malpica A, Deavers MT.

Int J Gynecol Pathol. 2011 Mar;30(2):158-62. doi: 10.1097/PGP.0b013e3181f9eba5. Review.

PMID:
21293284
15.

Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma.

Zhang C, Wang YE, Zhang P, Liu F, Sung CJ, Steinhoff MM, Quddus MR, Lawrence WD.

Hum Pathol. 2010 Feb;41(2):255-61. doi: 10.1016/j.humpath.2009.07.019. Epub 2009 Nov 6.

PMID:
19896693
16.

Cell polarity reversal in ovarian low-grade serous carcinomas and micropapillary serous borderline tumours: immunohistochemical observations.

Hui Y, Ou JJ, Sung CJ, Lawrence WD, Quddus MR.

Histopathology. 2016 Nov;69(5):892-894. doi: 10.1111/his.13013. Epub 2016 Aug 3. No abstract available.

PMID:
27271798
17.

Nanog is highly expressed in ovarian serous cystadenocarcinoma and correlated with clinical stage and pathological grade.

Pan Y, Jiao J, Zhou C, Cheng Q, Hu Y, Chen H.

Pathobiology. 2010;77(6):283-8. doi: 10.1159/000320866. Epub 2011 Jan 24.

PMID:
21266826
18.

Ovarian psammocarcinoma with peritoneal implants.

Cobellis L, Pezzani I, Cataldi P, Bome A, Santopietro R, Petraglia F.

Eur J Obstet Gynecol Reprod Biol. 2003 Apr 25;107(2):217-9.

PMID:
12648875
20.

Mixed angiosarcoma, clear cell adenocarcinoma and mature teratoma elements in an ovarian tumor: a case report and literature review.

Takahashi H, Chaopotong P, Kajita S, Hashimura M, Yamazaki H, Saegusa M.

Pathol Int. 2012 Aug;62(8):538-42. doi: 10.1111/j.1440-1827.2012.02831.x. Epub 2012 Jun 12. Review.

PMID:
22827762

Supplemental Content

Support Center